Sign in
4

Changes in Ownership

Spero Therapeutics, Inc. Filed Acc 0000899243-23-003939

CEO and President acquired 531,914 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mahadevia Ankit CEO and President 2023-02-01 Grant or award +531,914 810,118 D
Loading xslF345X03/doc4.xml…